Insmed's ARIKAYCE® Receives FDA Priority Review for Treating MAC Lung Disease #United_States #Bridgewater #Insmed #ARIKAYCE #MAC_Lung_Disease
@newsen.bsky.social
@newsen.bsky.socialInsmed's ARIKAYCE® Receives FDA Priority Review for Treating MAC Lung Disease #United_States #Bridgewater #Insmed #ARIKAYCE #MAC_Lung_Disease
@yoshitakahoshi.bsky.socialInsmedが呼吸器領域データを欧州呼吸器学会議2026で発表──ARIKAYCE第3b相ENCORE試験の最新結果を整理
stellanews.life/technology/1... #ENCORE試験 #ARIKAYCE
@yoshitakahoshi.bsky.socialInsmedが呼吸器領域データを欧州呼吸器学会議2026で発表──ARIKAYCE第3b相ENCORE試験の最新結果を整理
stellanews.life/technology/1... #ARIKAYCE #ENCORE試験
@newsen.bsky.socialInsmed to Showcase Key Findings from Its Respiratory Portfolio at ERS Congress 2026 #USA #Bridgewater #Insmed #ARIKAYCE #Brinsupri